Lybrel (levonorgestrel and ethinyl estradiol)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) June 2016 WARNINGS Thromboembolic Disorders and Other Vascular Problems Venous Thrombosis and Thromboembolism (addition of the...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts